JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orning, L.
Right arrow Articles by Fitzpatrick, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orning, L.
Right arrow Articles by Fitzpatrick, F. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 265, Issue 25, 14911-14916, Sep, 1990

Mechanism-based inactivation of leukotriene A4 hydrolase during leukotriene B4 formation by human erythrocytes

L Orning, DA Jones and FA Fitzpatrick
Department of Pharmacology C-236, University of Colorado Health Sciences Center, Denver 80262.

Evidence is presented in support of a mechanism-based (suicide) inactivation of leukotriene A4 hydrolyase in intact human erythrocytes by leukotriene A4 and leukotriene A4 methyl ester. Loss of enzymatic activity, accompanying leukotriene B4 formation, was proportional to the substrate concentration. Inactivation was directly related to the amount of leukotriene B4 formation: for several, different experimental protocols 50% loss of hydrolase activity corresponded with formation of 10.3 +/- 2.1 microM leukotriene B4. The time course of inactivation was pseudo-first order and obeyed saturation kinetics. Apparent inactivation (KI) and first-order rate (ki) constants for leukotriene A4 were 28 microM and 0.35 min-1, respectively. Leukotriene A4 methyl ester was also a site-directed inactivator with a similar KI = 25 microM and a ki = 0.1 min-1. For single incubations substrate instability limited the extent of inactivation to 50% of the initial enzyme activity. Following multiple, consecutive incubations with leukotriene A4 this increased and approached 80-90%; however, a residual activity of 10-20% suggested that a pool of enzyme was not susceptible to inactivation. Recovery of enzymatic activity, following inactivation, was negligible in intact erythrocytes and isolated enzyme. A single radiolabeled protein, corresponding to leukotriene A4 hydrolase, was detected by electrophoretic analysis of the incubation between [3H]leukotriene A4 and erythrocytes, or partially purified enzyme. Incorporation of [3H]leukotriene A4 methyl ester into enzyme was linearly related to its inactivation: 191 +/- 5 pmol incorporated corresponded to 10% loss of activity. Results conform to criteria for a mechanism-based inactivation, in which leukotriene A4 participates in two parallel processes, one leading to leukotriene B4 formation, the other to "suicide" inactivation of leukotriene A4 hydrolase in intact erythrocytes. The specific, rather than indiscriminate nature of this process has implications for the regulation of cellular leukotriene B4 formation. It may also afford a basis to monitor transcellular biosynthesis of leukotriene B4 in vivo.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. J. Askonas, J. F. Kachur, D. Villani-Price, C.-D. D. Liang, M. A. Russell, and W. G. Smith
Pharmacological Characterization of SC-57461A (3-[Methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic Acid HCl), a Potent and Selective Inhibitor of Leukotriene A4 Hydrolase I: In Vitro Studies
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 577 - 582.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Z. HAEGGSTROM
Structure, Function, and Regulation of Leukotriene A4 Hydrolase
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S25 - 31.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Mueller, M. Andberg, and J. Z. Haeggstrom
Analysis of the Molecular Mechanism of Substrate-mediated Inactivation of Leukotriene A4 Hydrolase
J. Biol. Chem., May 8, 1998; 273(19): 11570 - 11575.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Cadel, T. Foulon, A. Viron, A. Balogh, S. Midol-Monnet, N. Noel, and P. Cohen
Aminopeptidase B from the rat testis is a bifunctional enzyme structurally related to leukotriene-A4 hydrolase
PNAS, April 1, 1997; 94(7): 2963 - 2968.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Mueller, M. B. Andberg, B. Samuelsson, and J. Z. Haeggstrom
Leukotriene A4 Hydrolase, Mutation of Tyrosine 378Allows Conversion of Leukotriene A4 into an Isomer of Leukotriene B4
J. Biol. Chem., October 4, 1996; 271(40): 24345 - 24348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yokomizo, Y. Ogawa, N. Uozumi, K. Kume, T. Izumi, and T. Shimizu
cDNA Cloning, Expression, and Mutagenesis Study of Leukotriene B(4) 12-Hydroxydehydrogenase
J. Biol. Chem., February 2, 1996; 271(5): 2844 - 2850.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.